These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34598858)

  • 41. Relationship between salivary flow rate and clinical symptoms and behaviours in patients with dry mouth.
    Suh KI; Lee JY; Chung JW; Kim YK; Kho HS
    J Oral Rehabil; 2007 Oct; 34(10):739-44. PubMed ID: 17824886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship of hyposalivation and xerostomia in Mexican elderly with socioeconomic, sociodemographic and dental factors.
    Islas-Granillo H; Borges-Yáñez A; Fernández-Barrera MÁ; Ávila-Burgos L; Patiño-Marín N; Márquez-Corona ML; Mendoza-Rodríguez M; Medina-Solís CE
    Sci Rep; 2017 Jan; 7():40686. PubMed ID: 28094800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of Hyposalivation and Xerostomia: Criteria for Treatment Strategies.
    Epstein JB; Beier Jensen S
    Compend Contin Educ Dent; 2015 Sep; 36(8):600-3. PubMed ID: 26355444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How much saliva is enough for avoidance of xerostomia?
    Dawes C
    Caries Res; 2004; 38(3):236-40. PubMed ID: 15153694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Xerostomia and hyposalivation: a preliminary report of their prevalence and associated factors in Brazilian elderly diabetic patients.
    Borges BC; Fulco GM; Souza AJ; de Lima KC
    Oral Health Prev Dent; 2010; 8(2):153-8. PubMed ID: 20589249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
    Jensen SB; Vissink A
    Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significance of saliva for the denture-wearing population.
    Niedermeier W; Huber M; Fischer D; Beier K; Müller N; Schuler R; Brinninger A; Fartasch M; Diepgen T; Matthaeus C; Meyer C; Hector MP
    Gerodontology; 2000 Dec; 17(2):104-18. PubMed ID: 11808055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology.
    Cho MA; Ko JY; Kim YK; Kho HS
    J Oral Rehabil; 2010 Mar; 37(3):185-93. PubMed ID: 20002531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mouth dryness and burning sensation of the oral mucosa: causes and possibilities for treatment].
    Maier H; Tisch M
    HNO; 2003 Sep; 51(9):739-47. PubMed ID: 14504789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Xerostomia and hyposalivation.
    Nederfors T
    Adv Dent Res; 2000 Dec; 14():48-56. PubMed ID: 11842923
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Xerostomia. A common problem among the elderly.
    Bivona PL
    N Y State Dent J; 1998; 64(6):46-52. PubMed ID: 9707984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Xerostomia: etiology, recognition and treatment.
    Guggenheimer J; Moore PA
    J Am Dent Assoc; 2003 Jan; 134(1):61-9; quiz 118-9. PubMed ID: 12555958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Saliva on the oral mucosa and whole saliva in women diagnosed with burning mouth syndrome.
    Acharya S; Hägglin C; Jontell M; Wenneberg B; Ekström J; Carlén A
    Oral Dis; 2018 Nov; 24(8):1468-1476. PubMed ID: 29917294
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salivary hypofunction: an update on aetiology, diagnosis and therapeutics.
    Saleh J; Figueiredo MA; Cherubini K; Salum FG
    Arch Oral Biol; 2015 Feb; 60(2):242-55. PubMed ID: 25463902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salivary flow and its relation with oral symptoms in terminally ill patients.
    Chaushu G; Bercovici M; Dori S; Waller A; Taicher S; Kronenberg J; Talmi YP
    Cancer; 2000 Mar; 88(5):984-7. PubMed ID: 10699885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
    Malallah OS; Garcia CMA; Proctor GB; Forbes B; Royall PG
    Int J Pharm; 2018 Apr; 541(1-2):157-166. PubMed ID: 29425763
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Xerostomia, hyposalivation and oral microbiota in patients using antihypertensive medications.
    Nonzee V; Manopatanakul S; Khovidhunkit SO
    J Med Assoc Thai; 2012 Jan; 95(1):96-104. PubMed ID: 22379748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salivary Pacemakers: A review.
    Sarapur S; Shilpashree HS
    Dent Res J (Isfahan); 2012 Dec; 9(Suppl 1):S20-5. PubMed ID: 23814557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dry Mouth and Clinical Oral Dryness Scoring Systems.
    Das P; Challacombe SJ
    Prim Dent J; 2016 Feb; 5(1):77-79. PubMed ID: 29029657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.